-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Barinthus Biotherapeutics plc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- Barinthus Biotherapeutics plc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.2M, a 40% decline year-over-year.
- Barinthus Biotherapeutics plc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $3.65M, a 50.3% decline year-over-year.
- Barinthus Biotherapeutics plc. annual Share-based Payment Arrangement, Expense for 2023 was $5.06M, a 48.8% decline from 2022.
- Barinthus Biotherapeutics plc. annual Share-based Payment Arrangement, Expense for 2022 was $9.88M, a 40.1% decline from 2021.
- Barinthus Biotherapeutics plc. annual Share-based Payment Arrangement, Expense for 2021 was $16.5M, a 355% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)